Antibiotice Iaşi, one of the biggest local drug producers, controlled by the Health Ministry, plans to launch around 80 products in 2010-2012. Ioan Nani, the company's general manager, says these launches could double the company's turnover over the next two or three years. Between 2007-2008 the company's business fell by 4.3% at a time when the pharmaceutical market rose by an annual 10-15%.
Antibiotice announced the most aggressive product launch plan, while the remaining local producers plan to bring 10-20 drugs onto the market per year. The launches of local producers are important because prices are low compared with those of imported drugs, with the authorities seeking to encourage consumption of inexpensive drugs.
"The company intends to work on these 80 filings over the next two years, but there will be a prioritisation based on the company's advertising capacity and on the capacity of ANM (The National Drugs Agency), which authorises the selling of drugs i.e.), which will be under pressure. Provided that we launch all these products, our turnover could reach 120 million euros over the next two or three years," said Ioan Nani, general manager of Antibiotice Iaşi.
Antibiotice Iaşi, one of the biggest local drug producers, controlled by the Health Ministry, plans to launch around 80 products in 2010-2012. Ioan Nani, the company's general manager, says these launches could double the company's turnover over the next two or three years. Between 2007-2008 the company's business fell by 4.3% at a time when the pharmaceutical market rose by an annual 10-15%.
Antibiotice announced the most aggressive product launch plan, while the remaining local producers plan to bring 10-20 drugs onto the market per year. The launches of local producers are important because prices are low compared with those of imported drugs, with the authorities seeki
